For filings with the FCA include the annex
For filings with issuer exclude the annex
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached: ii		 Bioventix
(Sedol
B4QVDF0)
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights X
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the
notification obligation: iii		 CASTLEFIELD FUND PARTNERS LIMITED
4. Full name of shareholder(s)
 (if different from 3.):iv
5. Date of the transaction and date on
which the threshold is crossed or
reached: v		 9th  January 2017
6. Date on which issuer notified:                                                                    12th January 2017
7. Threshold(s) that is/are crossed or
reached: vi, vii		 5%

   

8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of
shares

if possible using
the ISIN CODE		 Situation previous
to the triggering
transaction		 Resulting situation after the triggering transaction
Number
of
Shares		 Number
of
Voting
Rights		 Number
of shares		 Number of voting
rights		 % of  voting rights x
Direct Direct xi Indirect xii Direct Indirect

GB00B4QVDF07		 250,000 250,000 265,000 265,000 5.197%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial
instrument		 Expiration
date xiii		 Exercise/
Conversion Period xiv		 Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.		 % of voting
rights
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial
instrument		 Exercise price Expiration date xvii Exercise/
Conversion period xviii		 Number of voting rights instrument refers to % of voting rights xix, xx
Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting rights
265,000 5.197%

   

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: xxi
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease
to hold:
12. Date on which proxy holder will cease to hold
voting rights:

13. Additional information:
Percentage based on Issued Share Capital of 5,098,656 
14. Contact name: Richard Vickers
15. Contact telephone number: 0161 233 4890

   

Note: Annex should only be submitted to the FSA not the issuer
Annex: Notification of major interests in sharesxxii
A: Identity of the persons or legal entity subject to the notification obligation
Full name
(including legal form of legal entities)
Contact address
(registered office for legal entities)
Phone number & email
Other useful information
(at least legal representative for legal persons)
B: Identity of the notifier, if applicable
Full name
Contact address
Phone number & email
Other useful information
(e.g. functional relationship with the person or legal entity subject to the notification obligation)
C: Additional information
For notes on how to complete form TR-1 please see the FSA website.

Copyright y 13 PR Newswire

Bioventix (LSE:BVXP)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Bioventix Charts.
Bioventix (LSE:BVXP)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Bioventix Charts.